Department of Assisted Reproduction, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, People's Republic of China.
College of Medicine, Anhui University of Science and Technology, Huainan 232000, People's Republic of China.
Hum Reprod. 2020 Feb 29;35(2):472-481. doi: 10.1093/humrep/dez282.
Do sperm-specific phospholipase C zeta (PLCZ1) mutations account for male infertility due to fertilization failure?
Six novel mutations and one reported mutation in PLCZ1 were identified in five of 14 independent families characterized by fertilization failure or poor fertilization, suggesting that these mutations may be responsible for fertilization failure in men exhibiting primary infertility.
PLCZ1 is essential for the induction of intracellular calcium (Ca2+) oscillations and the initiation of oocyte activation during mammalian fertilization. However, genetic evidence linking PLCZ1 mutations with male infertility remains limited.
STUDY DESIGN, SIZE, DURATION: Fourteen unrelated primary infertility patients were recruited into this study from January 2016 to December 2018; the patients exhibited total fertilization failure or poor fertilization, as evidenced by ICSI and sperm-related oocyte activation deficiencies identified in mouse oocyte activation assays.
PARTICIPANTS/MATERIALS, SETTING, METHODS: Genomic DNA samples were extracted from the peripheral blood of patients. The whole exons of PLCZ1 were sequenced by Sanger sequencing. The PLCZ1 sequences were aligned by CodonCode software to identify rare variants. The ExAC database was used to search for the frequency of corresponding mutations. The pathogenicity of identified variants and their possible effects on the protein were assessed in silico. PLCZ1 protein levels in semen samples were evaluated by western blotting. Oocyte activation ability was assessed by the injection of wild-type and mutant PLCZ1 cRNAs into human mature metaphase II (MII) oocytes in vitro.
We identified six novel mutations and one reported mutation in PLCZ1 among five affected individuals. In addition to four novel missense mutations, two new types of genetic variants were identified, including one in-frame deletion and one splicing mutation. Western blot analysis revealed that PLCZ1 protein expression was not observed in the semen samples from the five affected patients. Microinjection with the PLCZ1 cRNA variants was performed, and a significant decrease in the percentage of pronuclei was observed for four novel missense mutations and one novel in-frame deletion mutation, suggesting that these mutations have a deleterious influence on protein function. By artificial oocyte activation treatment, the fertilization failure phenotypes of four affected patients were successfully rescued and three healthy babies were delivered.
N/A.
LIMITATIONS, REASONS FOR CAUTION: We screened only the whole exons of PLCZ1. Additional possible mutations in the non-coding region of PLCZ1 should be further studied.
Our study not only further confirms the important role of PLCZ1 in human fertilization but also expands the mutational spectrum of PLCZ1 associated with male infertility, which provides a basis for assessing genetic variation in PLCZ1 as a potential diagnostic marker for infertile men suffering from fertilization failure.
STUDY FUNDING/COMPETING INTEREST(S): This research was supported by the National Natural Foundation of China (81 571 486 and 81 771 649). All authors have no conflicts of interest to declare.
精子特异性磷酯酶 C ζ(PLCZ1)突变是否导致受精失败导致的男性不育?
在 14 个独立的家族中,有 5 个家族表现出受精失败或受精不良,在这些家族中鉴定出了 6 个新突变和 1 个报告的 PLCZ1 突变,提示这些突变可能导致表现原发性不育的男性受精失败。
PLCZ1 对于哺乳动物受精过程中诱导细胞内钙(Ca2+)震荡和卵母细胞激活的起始是必需的。然而,将 PLCZ1 突变与男性不育联系起来的遗传证据仍然有限。
研究设计、大小、持续时间:从 2016 年 1 月至 2018 年 12 月,招募了 14 名患有原发性不育的无关患者;通过 ICSI 和小鼠卵母细胞激活试验证实精子相关卵母细胞激活缺陷,这些患者表现出总受精失败或受精不良。
参与者/材料、设置、方法:从患者外周血中提取基因组 DNA 样本。通过 Sanger 测序对 PLCZ1 的所有外显子进行测序。用 CodonCode 软件对 PLCZ1 序列进行比对,以识别稀有变异。使用 ExAC 数据库搜索相应突变的频率。通过计算机模拟评估鉴定出的变异及其对蛋白质的可能影响。通过 Western blot 评估精液样本中 PLCZ1 蛋白水平。通过将野生型和突变型 PLCZ1 cRNA 注入人成熟中期 II(MII)卵母细胞,评估卵母细胞激活能力。
在 5 名受影响的个体中,我们在 PLCZ1 中鉴定出了 6 个新突变和 1 个报告的突变。除了 4 个新的错义突变外,还鉴定出了两种新的遗传变异类型,包括 1 种框内缺失和 1 种剪接突变。Western blot 分析显示,5 名受影响患者的精液样本中未观察到 PLCZ1 蛋白表达。进行了 PLCZ1 cRNA 变体的微注射,发现 4 个新错义突变和 1 个新框内缺失突变的原核百分比显著降低,表明这些突变对蛋白功能具有有害影响。通过人工卵母细胞激活处理,成功挽救了 4 名受影响患者的受精失败表型,并成功分娩了 3 名健康婴儿。
无。
局限性、谨慎的原因:我们仅筛选了 PLCZ1 的整个外显子。应进一步研究 PLCZ1 非编码区的其他可能突变。
我们的研究不仅进一步证实了 PLCZ1 在人类受精中的重要作用,而且扩展了与男性不育相关的 PLCZ1 突变谱,为评估 PLCZ1 作为潜在的诊断标志物作为受精失败的不育男性提供了依据。
研究基金/利益冲突:本研究得到了国家自然科学基金(81571486 和 81771649)的支持。所有作者均无利益冲突。